14.40
0.00%
Close of 9 Nov 2026, in EUR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Rhoen Klinikum
Its shares trade on XETRA under the ticker RHK.DE. It has been listed since 27 November 1989. In the fiscal year to 31 December 2025, it reported revenue of €1.94bn and net income of €34.5m. At that date it held total assets of €1.82bn and shareholders' equity of €1.32bn.
Rhön-Klinikum AG engages in the provision of healthcare services. The company is headquartered in Bad Neustadt An Der Saale, Bayern. The company operates acute hospitals, medical care centers and rehabilitation hospitals across Germany: six clinics on Campus Bad Neustadt, including the Cardiovascular Clinic, the Frankenklinik for the Rehabilitation of Cardiovascular Patients, the Clinic for Hand Surgery, the Neurological Clinic, the Psychosomatic Clinic and the Saaletalklinik with two additional addiction therapy facilities; Klinikum Frankfurt (Oder) comprises clinics, psychiatric outpatient institutions and day clinics; University Hospital Giessen and Marburg (UKGM) offers medical services, modern diagnostics and comprehensive therapy in various areas, including ophthalmology, trauma surgery and dentistry, and Zentralklinik Bad Berka provides health care services to patients with thoracic, pulmonary and vascular diseases, tumors, neurological conditions, and diseases of the spinal column, joints and heart, among others.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 27 Nov 1989
- Employees
- 18,449
- Website
- rhoen-klinikum-ag.com ↗
Leadership
Pay as last reported
- Dr. Jan LierschChairman of the Supervisory Board, since 2020€103,000
- Prof. Dr. Tobias KaltenbachChairman of the Management Board, Chief Executive Officer€662,000
- Mr. Hafid RifiSecond Deputy Chairman of the Supervisory Board, since 2020€71,000
- Mr. Stefan RoehrhoffFirst Independent Deputy Chairman of the Supervisory Board, Employee Representative, since 2024€57,000
- Dr. Stefan StranzChief Financial Officer, Member of the Management Board€698,000
- Dr. Gunther WeissChief Operating Officer, Member of the Management Board€760,000
- Dr. Julia Dannath-SchuhIndependent Member of the Supervisory Board€33,000
- Mr. Peter BerghoeferMember of the Supervisory Board, Employee Representative€43,000
- Ms. Regina DickeyMember of the Supervisory Board, Employee Representative€44,000
- Mr. Peter DuckeMember of the Supervisory Board, Employee Representative€36,000
- Prof. Dr. Leopold EberhartMember of the Supervisory Board, Employee Representative€43,000
- Dr. Dagmar FederwischMember of the Supervisory Board€19,000
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 55
- Environment
- 65
- Social
- 77
- Governance
- 23
- Direct emissions (scope 1)
- 27,423 t
- Energy emissions (scope 2)
- 27,740 t
- Value chain emissions (scope 3)
- 274,276 t
- Women in the workforce
- 71%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Rhoen Klinikum AG has a strong reputation in the healthcare industry, known for providing high-quality medical services.
- The company has a large network of hospitals and medical facilities, allowing for a wide range of medical specialties and services.
- Rhoen Klinikum AG has a skilled workforce consisting of experienced medical professionals and staff members.
- The company has efficient operational processes in place, ensuring smooth functioning of its hospitals.
- Rhoen Klinikum AG has established strong partnerships with healthcare organizations and insurance providers, facilitating collaboration and patient referrals.
- The company enjoys a strong financial position, allowing for investments in advanced medical technologies and infrastructure.
Weaknesses
- Rhoen Klinikum AG may face challenges in attracting and retaining top talent in the highly competitive healthcare industry.
- The company's extensive network of hospitals may lead to difficulties in maintaining consistent quality standards across all locations.
- Rhoen Klinikum AG may have limited flexibility in decision-making due to its large size and bureaucratic processes.
- The company's reliance on traditional healthcare models may hinder its ability to adapt to emerging trends and technologies.
- Rhoen Klinikum AG operates in a heavily regulated industry, making compliance with legal and regulatory requirements a potential weakness.
- The company may be vulnerable to changes in government policies and healthcare reimbursement systems.
Opportunities
- Rhoen Klinikum AG can capitalize on the growing demand for specialized medical services, such as robotic surgeries or telemedicine.
- The company can expand its services to new markets or geographical areas, taking advantage of untapped patient populations.
- Rhoen Klinikum AG can invest in research and development to innovate and offer unique medical treatments or procedures.
- The company can enhance its employee training and development programs to foster a culture of continuous learning and improvement.
- Rhoen Klinikum AG can form strategic alliances or partnerships with technology companies to leverage digital solutions and improve patient care.
- The company can explore opportunities in medical tourism, attracting international patients seeking high-quality healthcare services.
Threats
- Rhoen Klinikum AG may face increased competition from other healthcare providers, both domestically and internationally.
- Changes in healthcare regulations and reimbursement policies can pose a threat to the company's financial stability.
- Rhoen Klinikum AG's organizational structure may hinder agility and responsiveness to market changes, limiting its competitive advantage.
- The company's dependence on third-party suppliers and vendors can expose it to supply chain risks and disruptions.
- The ongoing COVID-19 pandemic can impact Rhoen Klinikum AG's operations and patient volumes, leading to financial challenges.
- Technological advancements and the rise of telemedicine can disrupt traditional healthcare models and pose a threat to the company's market position.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.